Vimarsana
Biggest News Aggregation in the World

Page 4 - Pharma Medtech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Medtech Today - Breaking & Trending Today

Dublin clinical trials group Icon buys PRA in $12bn deal - Vimarsana News

Dublin clinical trials group Icon buys PRA in $12bn deal

Dublin clinical trials group Icon buys PRA in $12bn deal Combined group will form the world’s largest contract research organisation Wed, Feb 24, 2021, 11:31   Irish clinical trials group Icon, which employs more than 1,000 people in the Republic, is to acquire US company PRA Health Sciences in a $12 billion (€9.87 billion) deal. The combined company will form the world’s largest contract research organisation, and is to be headquartered at Icon’s Leopardstown campus in Dublin. The cash and stock deal is comprised of $80 per share in cash and 0.4125 shares of Icon stock. It represen...

Supply fears for Johnson & Johnson Covid vaccine doses - Vimarsana News

Supply fears for Johnson & Johnson Covid vaccine doses

White House adviser says only a few million doses will be available at expected US approval date

EU agrees deal for millions of additional Covid-19 vaccine doses - Vimarsana News

EU agrees deal for millions of additional Covid-19 vaccine doses

Commission also putting funds into studying and responding to new variants of disease

Back pain device group Mainstay Medical raises $108m - Vimarsana News

Back pain device group Mainstay Medical raises $108m

Back pain device group Mainstay Medical raises $108m Funding will drive commercialisation of Reactiv8 in critical US market Tue, Feb 16, 2021, 13:00 Updated: Tue, Feb 16, 2021, 18:24 Irish company Mainstay Medical has developed a device to address chronic lower back pain Your Web Browser may be out of date. If you are using Internet Explorer 9, 10 or 11 our Audio player will not work properly.   Irish company Mainstay Medical, which has developed a device to address chronic lower back pain, has raised $108 million(€89 million) to commercialise it in the US market. Mainstay, whi...

EMA expects Johnson & Johnson to file for vaccine approval within days - Vimarsana News

EMA expects Johnson & Johnson to file for vaccine approval within days

EMA expects Johnson & Johnson to file for vaccine approval within days New BioNTech production site will have capacity to produce 750m doses annually Fri, Feb 12, 2021, 17:04 Updated: Fri, Feb 12, 2021, 21:26 The first stage of BioNTech’s vaccine process, producing the active ingredient known as mRNA, has begun at a new plant in Marburg. Photograph: AFP via Getty   The European Medicines Agency (EMA) expects Johnson & Johnson to file for approval of its Covid-19vaccine in the EU within the next few days. Approval of this inoculation is viewed by many as pivotal in speeding up the ...